VC firm
XISTA Science Ventures
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- Austria
Claim, correct or request removal
Record updated 17 September 2026
About
XISTA Science Ventures is a venture capital firm dedicated to transforming cutting edge science into impactful businesses. Rooted in one of Europe’s leading research ecosystems, we bridge the gap between academic discovery and real world application across institutions, disciplines, and technologies.
Investment approach
- Thesis
- We partner early with scientists and support them in bringing ideas from the lab to the market. With expertise in life sciences, digital technologies, and industrial innovation, we provide capital alongside hands on support, strategic guidance, and access to strong networks and infrastructure.Source (opens in a new tab)
- Leads rounds
- Yes
- Lead policy
- The pre-seed round was co-led by XISTA Science Ventures and Caesar Ventures
- Takes board seats
- Yes
- Board policy
- XISTA is a trusted sparring partner on our board.
- Investing status notes
- Epitome Therapeutics Launches with €4 Million in Total Funding Following Oversubscribed Pre-Seed Round
Loading relationship preview